Metformin Testing Prompts New Finding Of NDMA And Cancer Risk

FDA Asks Several Manufacturers To Recall Products In US

Close up of Metformin prescription bottle with glucometer and testing strip container.
FDA issues new findings about NDMA in metformin • Source: Shutterstock

More from Manufacturing

More from Business